Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroblastoma × lutetium Lu 177 dotatate × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 15 Paraganglioma 5 Meningioma 5 Pheochromocytoma 4 Carcinoma, Neuroendocrine 4 Gastro-enteropancreatic neuroendocrine tumor 2 Carcinoma, Medullary 2 Carcinoid Tumor 2 Somatostatinoma 1 Serotonin Syndrome 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Parathyroid Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Medulloblastoma 1 Hypertension 1 Disease Progression 1 Carcinoma, Merkel Cell 1 Carcinoid Heart Disease 1 Advanced Lung Neuroendocrine Tumor 1 Adrenal Gland Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Cyclophosphamide 29 Etoposide 21 Isotretinoin 18 Topotecan 16 Temozolomide 16 Doxorubicin 16 Irinotecan 15 Carboplatin 15 Vincristine 14 sargramostim 13 Melphalan 12 Granulocyte-Macrophage Colony-Stimulating Factor 12 3-Iodobenzylguanidine 12 Radiotherapy 11 Cisplatin 11 dinutuximab 10 Magnetic Resonance Spectroscopy 9 Filgrastim 9 naxitamab 8 Peripheral Blood Stem Cell Transplantation 8 Thiotepa 7 humanized 3F8 anti-GD2 monoclonal antibody 6 X-Rays 6 Specimen Handling 6 Phantoms, Imaging 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Antilymphocyte Serum 6 fludarabine phosphate 5 aldesleukin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04903899 2025-02-11

LuDO-N

Karolinska University Hospital

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡